Studies have reported a significantly increase of CMPK2 expression in active SLE compared to healthy individuals and inactive SLE patients, making it a promising biomarker for diagnosis and evaluation of SLE activity (Xu et al., 2008; Li et al., 2022). Here, CMPK2 is linked to systemic lupus erythematosus.